Lv3
216 积分 2021-12-09 加入
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: a multicenter, randomized phase II trial
16小时前
已完结
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
27天前
已完结
Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors
27天前
已完结
Effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis evaluated by transient elastography in patients with type 2 diabetes and nonalcoholic fatty liver disease
27天前
已完结
Impact of oral anti-diabetes medication on liver fat in type 2 diabetes mellitus and non alcoholic fatty liver: RCT
27天前
已完结
Open prospective randomized controlled study on the effects of SGLT2 inhibitor and bezafibrate on blood glucose control and NAFLD (nonalcoholic fatty liver disease)/START study
27天前
已关闭
皖公网安备34019202002308
